BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

449 related articles for article (PubMed ID: 7908703)

  • 1. Changes in AIDS survival time in two San Francisco cohorts of homosexual men, 1983 to 1993.
    Osmond D; Charlebois E; Lang W; Shiboski S; Moss A
    JAMA; 1994 Apr; 271(14):1083-7. PubMed ID: 7908703
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predictors for failure of Pneumocystis carinii pneumonia prophylaxis. Multicenter AIDS Cohort Study.
    Saah AJ; Hoover DR; Peng Y; Phair JP; Visscher B; Kingsley LA; Schrager LK
    JAMA; 1995 Apr; 273(15):1197-202. PubMed ID: 7707627
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of therapeutic and prophylactic drugs for AIDS by homosexual and bisexual men in three US cities.
    Holmberg SD; Conley LJ; Buchbinder SP; Judson FN; Bush TJ; Katz MH; Penley KA; Hershow RC
    AIDS; 1993 May; 7(5):699-704. PubMed ID: 8318177
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Depressive symptoms and CD4 lymphocyte decline among HIV-infected men.
    Burack JH; Barrett DC; Stall RD; Chesney MA; Ekstrand ML; Coates TJ
    JAMA; 1993 Dec; 270(21):2568-73. PubMed ID: 7901433
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pneumocystis prophylaxis and survival in patients with advanced human immunodeficiency virus infection treated with zidovudine. The Zidovudine Epidemiology Group.
    Chaisson RE; Keruly J; Richman DD; Moore RD
    Arch Intern Med; 1992 Oct; 152(10):2009-13. PubMed ID: 1417373
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical manifestations of AIDS in the era of pneumocystis prophylaxis. Multicenter AIDS Cohort Study.
    Hoover DR; Saah AJ; Bacellar H; Phair J; Detels R; Anderson R; Kaslow RA
    N Engl J Med; 1993 Dec; 329(26):1922-6. PubMed ID: 7902536
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Benefit of primary prophylaxis before 18 months of age in reducing the incidence of Pneumocystis carinii pneumonia and early death in a cohort of 112 human immunodeficiency virus-infected infants. New York City Perinatal HIV Transmission Collaborative Study Group.
    Thea DM; Lambert G; Weedon J; Matheson PB; Abrams EJ; Bamji M; Straus WL; Thomas PA; Krasinski K; Heagarty M
    Pediatrics; 1996 Jan; 97(1):59-64. PubMed ID: 8545225
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ten-year trends in CD4 cell counts at HIV and AIDS diagnosis in a London HIV clinic.
    Easterbrook PJ; Yu LM; Goetghebeur E; Boag F; McLean K; Gazzard B
    AIDS; 2000 Mar; 14(5):561-71. PubMed ID: 10780719
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changes in survival after acquired immunodeficiency syndrome (AIDS): 1984-1991.
    Jacobson LP; Kirby AJ; Polk S; Phair JP; Besley DR; Saah AJ; Kingsley LA; Schrager LK
    Am J Epidemiol; 1993 Dec; 138(11):952-64. PubMed ID: 7903022
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of routine use of therapy in slowing the clinical course of human immunodeficiency virus (HIV) infection in a population-based cohort.
    Longini IM; Clark WS; Karon JM
    Am J Epidemiol; 1993 Jun; 137(11):1229-40. PubMed ID: 8100682
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discontinuation of secondary prophylaxis against Pneumocystis carinii pneumonia in patients with HIV infection who have a response to antiretroviral therapy. Eight European Study Groups.
    Ledergerber B; Mocroft A; Reiss P; Furrer H; Kirk O; Bickel M; Uberti-Foppa C; Pradier C; D'Arminio Monforte A; Schneider MM; Lundgren JD;
    N Engl J Med; 2001 Jan; 344(3):168-74. PubMed ID: 11188837
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Secular trends in the survival of HIV-infected homosexual men in Amsterdam and Vancouver estimated from a death-included CD4-staged Markov model.
    Hendriks JC; Craib KJ; Veugelers PJ; van Druten HA; Coutinho RA; Schechter MT; van Griensven GJ
    Int J Epidemiol; 2000 Jun; 29(3):565-72. PubMed ID: 10869332
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evolving trends revealed by autopsies of patients with the acquired immunodeficiency syndrome. 565 autopsies in adults with the acquired immunodeficiency syndrome, Los Angeles, Calif, 1982-1993 [corrected].
    Klatt EC; Nichols L; Noguchi TT
    Arch Pathol Lab Med; 1994 Sep; 118(9):884-90. PubMed ID: 8080357
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term survival without clinical AIDS after CD4+ cell counts fall below 200 x 10(6)/l.
    Hoover DR; Rinaldo C; He Y; Phair J; Fahey J; Graham NM
    AIDS; 1995 Feb; 9(2):145-52. PubMed ID: 7718184
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prophylaxis against Pneumocystis carinii pneumonia among children with perinatally acquired human immunodeficiency virus infection in the United States. Pneumocystis carinii Pneumonia Prophylaxis Evaluation Working Group.
    Simonds RJ; Lindegren ML; Thomas P; Hanson D; Caldwell B; Scott G; Rogers M
    N Engl J Med; 1995 Mar; 332(12):786-90. PubMed ID: 7862183
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Discontinuation of Pneumocystis carinii pneumonia prophylaxis after start of highly active antiretroviral therapy in HIV-1 infection. EuroSIDA Study Group.
    Weverling GJ; Mocroft A; Ledergerber B; Kirk O; Gonzáles-Lahoz J; d'Arminio Monforte A; Proenca R; Phillips AN; Lundgren JD; Reiss P
    Lancet; 1999 Apr; 353(9161):1293-8. PubMed ID: 10218526
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effects on survival of early treatment of human immunodeficiency virus infection.
    Graham NM; Zeger SL; Park LP; Vermund SH; Detels R; Rinaldo CR; Phair JP
    N Engl J Med; 1992 Apr; 326(16):1037-42. PubMed ID: 1347907
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pneumocystis jiroveci pneumonia prophylaxis is not required with a CD4+ T-cell count < 200 cells/microl when viral replication is suppressed.
    D'Egidio GE; Kravcik S; Cooper CL; Cameron DW; Fergusson DA; Angel JB
    AIDS; 2007 Aug; 21(13):1711-5. PubMed ID: 17690568
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cryptosporidiosis among patients infected with human immunodeficiency virus. Factors related to symptomatic infection and survival.
    Colford JM; Tager IB; Hirozawa AM; Lemp GF; Aragon T; Petersen C
    Am J Epidemiol; 1996 Nov; 144(9):807-16. PubMed ID: 8890659
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Progression of human immunodeficiency virus type 1 (HIV-1) infection among homosexual men in hepatitis B vaccine trial cohorts in Amsterdam, New York City, and San Francisco, 1978-1991.
    Hessol NA; Koblin BA; van Griensven GJ; Bacchetti P; Liu JY; Stevens CE; Coutinho RA; Buchbinder SP; Katz MH
    Am J Epidemiol; 1994 Jun; 139(11):1077-87. PubMed ID: 8192140
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.